Category: Bruker Corp.Syndicate content

SEC dings Bruker in $2.4m China bribery case

December 15, 2014 by Brad Perriello

The SEC dings Bruker Corp. for $2.4 million to settle charges that it broke the Foreign Corrupt Practices Act by paying off Chinese officials to win business there but admitted no wrongdoing.

SEC dings Bruker in $2.4m China bribery case

ConMed closes tender offer for Viking Systems | Wall Street Beat

September 24, 2012 by MassDevice staff

ConMed closes its 27¢-per-share tender offer for medical imaging company Viking Systems, giving it about 84% of Viking as it looks to close its short-form merger.

MassDevice.com Wall Street Beat

ConMed (NSDQ:CNMD) said it's closed its 27¢-per-share tender offer for Viking Systems (OTC:VKNG), leaving it with about 84% of shares in the medical imaging maker.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Bruker tanks on Q2 earnings forecast | Wall Street Beat

July 24, 2012 by MassDevice staff

Shares of Bruker Corp. are down nearly 12% today after the medical device company cut its earnings forecast in half.

MassDevice.com Wall Street Beat

Bruker Corp. (NSDQ:BRKR) shares took a double-digit dive this morning after the medical device company said it expects the European fiscal crisis to cut its 2ns-quarter per-share earnings roughly in half.

Bruker said it expects to report adjusted EPS of 11¢-13¢ for the 3 months ended June 30, on sales of about $420 million. Wall Street analysts were expecting adjusted EPS of 21¢.

Bruker names Charles Wagner Jr. CFO | Personnel Moves

June 7, 2012 by MassDevice staff

Bruker Corp. named former board member Charles Wagner Jr. it's new CFO and executive vice president.

fired/hired

 Bruker names Charles Wagner Jr. executive VP and CFO

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Boston Scientific launches Pluromed's BackStop kidney stone treatment | Wall Street Beat

April 2, 2012 by MassDevice staff

Boston Scientific launches its BackStop kidney stone treatment, licensed from Pluromed, in the U.S. and certain international markets; also, Siemens lands 3rd year defense contract worth up to $1.9 billion; Bruker Corp. nabs all shares of SkyScan for an undisclosed amount; Viking expects 40% sales growth for Q1 2012; Smith & Nephew acquires LifeModeler for an undisclosed amount; Wound Care Innovations signs exclusive N.A.

MassDevice.com Wall Street Beat

Boston Scientific (NYSE:BSX) launched its BackStop kidney stone treatment product in the U.S. and certain international markets this week.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Is J&J in the hunt for Boston Scientific? | Acquisitions Roundup

September 15, 2011 by MassDevice staff

Could the installation of Johnson & Johnson's top medical device exec as bitter rival Boston Scientific's new CEO could signal the conglomerate's interest in acquiring BSX?; also, Integra to pay $65 million for Ascension Orthopedics; Solta Medical buys LipoSonix from Medicis for $15 million; Vasomedical buys Chinese suppliers; Hill-Rom pays $20 million for French, Swiss distributors; Bruker to buy CETR; Elekta closes Nucletron deal; and DGT Holdings deals Italian subsidiary to VIV for $22.5 million.

Johnson & Johnson
Boston Scientific

Could the amicable deal between bitter rivals Johnson & Johnson (NYSE:JNJ) and Boston Scientific (NYSE:BSX) over Michael Mahoney leaving J&J to helm BSX signal an upcoming acquisition?

Opinions are divided on Wall Street, with at least one analyst wondering if a deal could be in the works and others casting doubt on the speculation.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Bruker Announces Agreement to Acquire CETR

September 15, 2011 by MassDevice staff

Source: 
BusinessWire

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation today announced the signing of a purchase agreement
to acquire Center for Tribology, Inc. (CETR) for an undisclosed amount.
CETR, a privately held corporation located in Silicon Valley in
Campbell, CA, is projected to have calendar year 2011 revenue greater
than $10 million and EBITDA greater than $2 million. The transaction is
expected to close at the end of the third quarter of 2011, subject to
customary closing conditions. After the closing, Bruker intends to
continue to operate CETR in Silicon Valley and to integrate its business
management, operations, research and development, sales and support with

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp